SCHEMBL16710375

SCHEMBL16710375

CC(C)=CCc1cc(C(=O)Nc2cc3ccc(OCCCN(C)C4CCCCC4)c(C)c3oc2=O)ccc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 15/20 0.64
HSP90AB1 P08238 15/20 0.64
POLQ O75417 1/20 0.41
ALB P02768 1/20 0.41
KDR P35968 1/20 0.41
MAP1LC3B Q9GZQ8 1/20 0.41
MAP1LC3A Q9H492 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
KDM4E B2RXH2 2/20 0.39
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
RECQL P46063 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTT P42858 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20668541 0.97 HSP90AA1 (0.62) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL1608020 0.89 HSP90AA1 (0.65) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL16702149 0.87 HSP90AA1 (0.65) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL16702536 0.87 HSP90AA1 (0.62) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL16701883 0.87 HSP90AA1 (0.65) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL1607389 0.87 HSP90AA1 (0.66) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL16702655 0.86 HSP90AA1 (0.62) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL16710344 0.86 HSP90AA1 (0.63) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL20668542 0.86 HSP90AA1 (0.64) HSP90AA1HSP90AB1POLQALBKDR
SCHEMBL16702260 0.85 HSP90AA1 (0.62) HSP90AA1HSP90AB1POLQALBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745386-B2 Coumarin based HSP90 inhibitors with urea and ether substituents UNIVERSITY OF KANSAS (US) 2020-08-18 US disclosed
US-20160289217-A1 COUMARIN BASED HSP90 INHIBITORS WITH UREA AND ETHER SUBSTITUENTS UNIVERSITY OF KANSAS (US) 2016-10-06 US disclosed
WO-2015070238-A2 COUMARIN BASED HSP90 INHIBITORS WITH UREA AND ETHER SUBSTITUENTS THE UNIVERSITY OF KANSAS (US) 2015-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10745386-B2 Coumarin based HSP90 inhibitors with urea and ether substituents HSP90B1, HSP90AA1, HSP90AB1 HSP90AA1 2/4885HSP90AB1 3/4885POLQ 2396/4885
US-20160289217-A1 COUMARIN BASED HSP90 INHIBITORS WITH UREA AND ETHER SUBSTITUENTS HSP90B1, HSP90AA1, HSP90AB1 HSP90AA1 2/4885HSP90AB1 3/4885POLQ 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.